Mesothelioma not associated with asbestos exposure.

CONTEXT Despite asbestos being identified as the single most important cause of malignant mesothelioma, the tumor is known to occur in only 10% to 20% of heavily exposed individuals. In addition, about 20% of the patients have no history of asbestos exposure even after detailed assessment. Therefore, there has been speculation for some time that asbestos alone may not be sufficient to cause mesothelioma and that other factors may be involved either as cocarcinogens or as independent mechanisms of cancer causation. OBJECTIVE To give a brief review of nonasbestos fiber erionite and therapeutic radiation as 2 established examples of asbestos-independent mechanisms, of the potential emerging role of man-made fibers such as carbon nanotubes, and of polyoma virus SV40 (simian virus 40) as a potential example of the cocarcinogenic mode of involvement. DATA SOURCES Relevant recent literature has been surveyed to portray and provide the evidence in favor of the examples. CONCLUSIONS Erionite has emerged as the most important example of nonasbestos-mediated cause of mesothelioma in regions such as Turkey where exposure to this type of fiber is highly prevalent. Recently, the polyoma virus SV40 has been unexpectedly discovered as an effective cocarcinogen of asbestos in the causation of animal mesothelioma, though despite considerable research, its potential role in human mesothelioma remains unproven.

[1]  B. Christensen,et al.  SV40 associated miRNAs are not detectable in mesotheliomas , 2010, British Journal of Cancer.

[2]  G. Hillerdal,et al.  Endemic Malignant Mesothelioma: Exposure to Erionite Is More Important Than Genetic Factors , 2010, Archives of environmental & occupational health.

[3]  Craig A. Poland,et al.  Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma , 2010, Particle and Fibre Toxicology.

[4]  M. Jaurand,et al.  Particle and Fibre Toxicology Mesothelioma: Do Asbestos and Carbon Nanotubes Pose the Same Health Risk? , 2022 .

[5]  P. Valberg,et al.  Ionizing radiation: a risk factor for mesothelioma , 2009, Cancer Causes & Control.

[6]  E. Noordijk,et al.  Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. , 2009, Blood.

[7]  J. Peto,et al.  Occupational, domestic and environmental mesothelioma risks in the British population: a case–control study , 2009, British Journal of Cancer.

[8]  Akihiko Hirose,et al.  Induction of mesothelioma by a single intrascrotal administration of multi-wall carbon nanotube in intact male Fischer 344 rats. , 2009, The Journal of toxicological sciences.

[9]  T. Oury,et al.  North american erionite-associated mesothelioma with pleural plaques and pulmonary fibrosis: a case report. , 2009, International journal of clinical and experimental pathology.

[10]  Craig A. Poland,et al.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.

[11]  M. Nicolson,et al.  Pericardial malignant mesothelioma: a latent complication of radiotherapy? , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[12]  J. Hoskins,et al.  Erionite series minerals: mineralogical and carcinogenic properties , 2008, Environmental geochemistry and health.

[13]  J. Kanno,et al.  Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. , 2008, The Journal of toxicological sciences.

[14]  S. Grunberg,et al.  Malignant mesothelioma following thoracic radiotherapy for lung cancer. , 2007, Lung cancer.

[15]  N. Wolmark,et al.  An Association Between Postoperative Radiotherapy for Primary Breast Cancer in 11 National Surgical Adjuvant Breast and Bowel Project (NSABP) Studies and the Subsequent Appearance of Pleural Mesothelioma , 2007, American journal of clinical oncology.

[16]  P. Hall,et al.  Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  E. Lau,et al.  Therapeutic radiation for lymphoma , 2007, Cancer.

[18]  Bingshu E. Chen,et al.  Risk of second non-hematological malignancies among 376,825 breast cancer survivors , 2007, Breast Cancer Research and Treatment.

[19]  R. Kennedy,et al.  SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen , 2007, Cellular and Molecular Life Sciences.

[20]  B. Robinson,et al.  A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent. , 2006, Cancer research.

[21]  H. Pass,et al.  Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters , 2006, Proceedings of the National Academy of Sciences.

[22]  J. Decaprio,et al.  Is there a role for SV40 in human cancer? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Tward,et al.  The risk of secondary malignancies over 30 years after the treatment of non‐Hodgkin lymphoma , 2006, Cancer.

[24]  M. G. Putzu,et al.  Fluoro-edenitic fibres in the sputum of subjects from Biancavilla (Sicily): a pilot study , 2006, Environmental health : a global access science source.

[25]  Salih Emri,et al.  Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. , 2006, Cancer research.

[26]  P. Grandjean,et al.  Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite. , 2006, Journal of the National Cancer Institute.

[27]  John D Boice,et al.  Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. , 2005, Journal of the National Cancer Institute.

[28]  J. I. Phillips,et al.  Evidence against a role for SV40 in human mesothelioma. , 2005, Cancer research.

[29]  A. Dogan,et al.  Malignant Mesothelioma and Erionite , 2005 .

[30]  M. Carbone,et al.  SV40-Mediated Oncogenesis , 2005 .

[31]  Y. Ishikawa,et al.  Lack of apparent excess of malignant mesothelioma but increased overall malignancies of peritoneal cavity in Japanese autopsies with Thorotrast injection into blood vessels , 2005, Journal of Cancer Research and Clinical Oncology.

[32]  M. Ladanyi,et al.  Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids , 2004, The Lancet.

[33]  J. Cerhan,et al.  Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States. , 2004, Journal of the National Cancer Institute.

[34]  R. Pasetto,et al.  Pulmonary fibre burden in sheep living in the Biancavilla area (Sicily): preliminary results. , 2004, The Science of the total environment.

[35]  Bertram Price,et al.  Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. , 2004, American journal of epidemiology.

[36]  P. Hall,et al.  Site-Specific Cancer Incidence and Mortality after Cerebral Angiography with Radioactive Thorotrast , 2003, Radiation research.

[37]  H. Pass,et al.  New developments about the association of SV40 with human mesothelioma , 2003, Oncogene.

[38]  R. Garcea,et al.  Simian Virus 40 Infection of Humans , 2003, Journal of Virology.

[39]  Pietro Comba,et al.  Pleural Mesothelioma Cases in Biancavilla are Related to a New Fluoro-Edenite Fibrous Amphibole , 2003, Archives of environmental health.

[40]  A. Gazdar,et al.  SV40 and human tumours: myth, association or causality? , 2002, Nature Reviews Cancer.

[41]  O. Haas,et al.  Absence of SV40 in Austrian Tumors Correlates with Low Incidence of Mesotheliomas , 2002, Cancer biology & therapy.

[42]  Robert A. Weinberg,et al.  Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation , 2002, Molecular and Cellular Biology.

[43]  J. Testa,et al.  The pathogenesis of mesothelioma. , 2002, Seminars in oncology.

[44]  Donna A. Almario,et al.  Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer , 2003 .

[45]  R. Saracci,et al.  Familial malignant mesothelioma , 2001, The Lancet.

[46]  P. Hall,et al.  Mortality after Cerebral Angiography with or without Radioactive Thorotrast: An International Cohort of 3,143 Two-Year Survivors , 2001, Radiation research.

[47]  H. Strickler,et al.  A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[48]  M. Mason,et al.  Simian virus 40 detection in human mesothelioma: reliability and significance of the available molecular evidence. , 2001, Frontiers in bioscience : a journal and virtual library.

[49]  P De Vuyst,et al.  Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzköy, Cappadocia, Turkey , 2001, Occupational and environmental medicine.

[50]  J. Testa,et al.  Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey , 2001, The Lancet.

[51]  A. Gazdar,et al.  Association of SV40 with human tumours. , 2001, Seminars in cancer biology.

[52]  M Nesti,et al.  Unusually High Incidence of Malignant Pleural Mesothelioma in a Town of Eastern Sicily: An Epidemiological and Environmental Study , 2000, Archives of environmental health.

[53]  H. Pass,et al.  Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[54]  G. van Kaick,et al.  The german thorotrast study: recent results and assessment of risks. , 1999, Radiation research.

[55]  M. Pras,et al.  Pulmonary associations in familial Mediterranean fever. , 1999, Current opinion in pulmonary medicine.

[56]  T. Bayer,et al.  Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53. , 1999, Cancer research.

[57]  A. Neugut,et al.  Incidence of malignant pleural mesothelioma after thoracic radiotherapy , 1997, Cancer.

[58]  W. Travis,et al.  Post‐irradiation malignant mesothelioma , 1996, Cancer.

[59]  L. D. Galán,et al.  Sedimentary zeolites in the Sierra Madre del Sur and Sierra Madre Occidental, Mexico , 1996 .

[60]  H. Wallin,et al.  Lung carcinoma and malignant mesothelioma in patients exposed to thorotrast: Incidence, histology and p53 status , 1995, International journal of cancer.

[61]  B. Marincek,et al.  Malignant Peritoneal Mesothelioma After Thorotrast Exposure , 1995, American journal of clinical oncology.

[62]  H. Libshitz,et al.  Malignant pleural mesothelioma after radiation therapy for breast cancer. A report of two additional patients , 1995, Cancer.

[63]  J. Benichou,et al.  Malignant mesothelioma: attributable risk of asbestos exposure. , 1994, Occupational and environmental medicine.

[64]  M. Goodman,et al.  A case-control study of mesothelioma and employment in the Hawaii sugarcane industry. , 1994, Epidemiology.

[65]  H. Pass,et al.  Simian virus 40-like DNA sequences in human pleural mesothelioma. , 1994, Oncogene.

[66]  A. D. McDonald,et al.  Mesothelioma: is there a background , 1994 .

[67]  C. Cicala,et al.  SV40 induces mesotheliomas in hamsters. , 1993, The American journal of pathology.

[68]  R. J. Hill,et al.  Intrapleural Administration of Fibres Induces Mesothelioma in Rats in the same Relative Order of Hazard as Occurs in Man after Exposure , 1992, Human & experimental toxicology.

[69]  B. Gilks,et al.  Malignant peritoneal mesothelioma after remote abdominal radiation , 1988, Cancer.

[70]  L. Simonato,et al.  Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: A four‐year study in the cappadocian region of turkey , 1987, International journal of cancer.

[71]  V. Roggli,et al.  Pleural malignant mesothelioma following Wilms' tumor. , 1986, American journal of clinical pathology.

[72]  R. Newman Fine biogenic silica fibres in sugar cane: a possible hazard. , 1986, The Annals of occupational hygiene.

[73]  K. Anderson,et al.  Malignant pleural mesothelioma following radiotherapy in a 16‐year‐old boy , 1985, Cancer.

[74]  G. Hillerdal,et al.  Malignant mesothelioma secondary to chronic inflammation and old scars. Two new cases and review of the literature , 1985, Cancer.

[75]  R. J. Hill,et al.  Erionite exposure and mesotheliomas in rats. , 1985, British Journal of Cancer.

[76]  N. Kohyama,et al.  Malignant mesothelioma induced by asbestos and zeolite in the mouse peritoneal cavity. , 1984, Environmental research.

[77]  P. Buffler,et al.  Non‐asbestos‐related malignant mesothelioma. A review , 1984, Cancer.

[78]  J. Bignon,et al.  Ferruginous bodies in sputum as an indication of exposure to airborne mineral fibers in the mesothelioma villages of Cappadocia. , 1984, Archives of environmental health.

[79]  D. Henson,et al.  Malignant mesothelioma following radiation exposure. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  G. Roviaro,et al.  The association of pleural mesothelioma and tuberculosis. , 1982, The American review of respiratory disease.

[81]  A. Moossa,et al.  Peritoneal malignant mesothelioma in a patient with recurrent peritonitis , 1981, Cancer.

[82]  L. Simonato,et al.  MALIGNANT MESOTHELIOMA AND RADIOLOGICAL CHEST ABNORMALITIES IN TWO VILLAGES IN CENTRAL TURKEY An Epidemiological and Environmental Investigation , 1981, The Lancet.

[83]  J. Bignon,et al.  Zeolite bodies in human lungs from Turkey. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[84]  P. Elmes Fibrous minerals and health , 1980, Journal of the Geological Society.

[85]  Y. Bariş,et al.  Malignant mesotheliomas in a small village in the Anatolian region of Turkey: an epidemiologic study. , 1979, Journal of the National Cancer Institute.

[86]  Y. Bariş,et al.  An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgüp in Anatolia. , 1978, Thorax.

[87]  R. Maurer,et al.  Malignant peritoneal mesothelioma after cholangiography with thorotrast , 1975, Cancer.

[88]  P. E. Bernatz,et al.  Diffuse malignant mesothelioma of the pleura: a review of 37 cases. , 1971, Chest.

[89]  A. Langlois,et al.  Mesotheliomas of peritoneum, epicardium, and pericardium induced by strain MC29 avian leukosis virus. , 1970, Cancer research.

[90]  S. Dahlgren EFFECTS OF LOCALLY DEPOSITED COLLOIDAL THORIUM DIOXIDE , 1967, Annals of the New York Academy of Sciences.

[91]  C. Gold A primary mesothelioma involving the rectovaginal septum and associated with beryllium. , 1967, The Journal of pathology and bacteriology.

[92]  J. Wagner,et al.  Experimental Production of Mesothelial Tumours of the Pleura by Implantation of Dusts in Laboratory Animals , 1962, Nature.

[93]  F. Legallais,et al.  Lung tumors produced by intratracheal inoculation of polyoma virus in Syrian hamsters. , 1960, Journal of the National Cancer Institute.

[94]  M. Stanton,et al.  Oncogenic effect of tissue-culture preparations of polyoma virus on fetal mice. , 1959, Journal of the National Cancer Institute.

[95]  W. Hueper Experimental studies in metal cancerigenesis. I. Nickel cancers in rats. , 1952, Texas reports on biology and medicine.